Page 24 - OHKF_Biotech_EN

2
•
Rapid growth of the Industry | The significance of HK-SZ
The Competitive Edge of the HK-SZ Biotech Development and the Significance of the Co-operation
Shenzhen’s biomedical industry has experienced rapid growth in collaboration
recent years. In 2020, the industry’s contribution to the city’s The development of the GBA and the Pilot Demonstration Area of
GDP grew by a phenomenal 24.4%, the fastest pace among its Socialism with Chinese Characteristics (i.e., the “Two Areas”)
seven new industries of strategic importance. By 2025, the total presents Hong Kong and Shenzhen with enormous opportunities.
economic output of the industry is expected to exceed 200 billions By exploring policy innovations and the bridging of different systems,
RMB. The city has established a biomedical supply chain HK-SZ collaborations on biotech in the Loop can help steer a new
that integrates drug manufacturing, medical devices and course in cross-border collaboration under “One Country, Two
pharmaceutical distribution. Shenzhen is also leading the country Systems”, three customs territories, and three legal systems.
in medical equipment specialisations such as gene sequencing
and medical imaging, and has developed biomedical With its formidable scientific research capabilities, robust market
specialisations like stem cells and vaccines. Among its nationally economic system and world-class business environment, Hong
leading enterprises are Salubris, Sanofi, China Resources Sanjiu, Kong provides biotech enterprises with plentiful and efficient
Joincare, Hepalink, Sinopharm Zhijun, Mindray Medical, BGI financing opportunities. Meanwhile, Shenzhen has a solid foundation
Group, Beike Biotech and Neptunus Bioengineering, in addition to in a multitude of manufacturing industries as well as information and
start-ups like Chipscreen and Ausa Pharmed. As of March 2021, communications technologies. This, coupled with proactive
Shenzhen is home to 21 publicly listed biotech enterprises. government support, is conducive to the speedy transformation of
14
Meanwhile, many leading AI enterprises are expanding into biotech research outcomes into actual productive capabilities. On
biotech, utilising AI and medical technology to improve screening the one hand, HK-SZ collaboration can help Shenzhen achieve a
and diagnosis. Examples include Tencent Healthcare and Ping An system and mechanism for high-quality development; foster a stable,
Technology’s Smart Healthcare platform. fair, transparent and world-renowned business environment

14 Of these, ten are on the Main Board, eight on the Growth Enterprise Market and three on the Shanghai Stock Exchange’s Sci-Tech Innovation Board.
22